Line 1: | Line 1: | ||
{{Aix-Marseille|title=M13 part improvement|toc=__NOTOC__}} | {{Aix-Marseille|title=M13 part improvement|toc=__NOTOC__}} | ||
− | As we | + | As we wanted to make phage like particles, we needed to use a [[Team:Aix-Marseille/M13_Design#Phagemid|M13 phagemid]]. |
− | + | Initially we tried using [http://parts.igem.org/Part:BBa_K1445000 BBa_K1445000]. | |
+ | After a transforming TG1 with the biobrick we selected colonies, on chloramphenicol, and infected them with helper phage (M13KO7). | ||
− | + | We then purified [[Team:Aix-Marseille/Experiments/Protocols#Production_of_large_quantities_of_helper_phage|phage]] and infected ''E.coli'' GM1 bacteria with the resulting preparation. | |
After an overnight grow, we counted the colonies. | After an overnight grow, we counted the colonies. |
Revision as of 21:58, 1 November 2017
M13 part improvement
As we wanted to make phage like particles, we needed to use a M13 phagemid. Initially we tried using [http://parts.igem.org/Part:BBa_K1445000 BBa_K1445000]. After a transforming TG1 with the biobrick we selected colonies, on chloramphenicol, and infected them with helper phage (M13KO7).
We then purified phage and infected E.coli GM1 bacteria with the resulting preparation.
After an overnight grow, we counted the colonies. Here are the results for the M13 from the BBa_K1445000, and the pBlueScript II plasmid that we used:
In this experiment, for better results, everything was done three times, and these results are averages.
BBa_K1445000 | pBlueScript II | ||||||
Ampicilin | Kanamycin | Ampicilin + Kanalycin | Chloramphenicol | Kanamycin | Chloramphenicol + Kanamycin | ||
1µL | 162 | 606 | 1 | 1µL | 0 | 957 | 0 |
10⁻² | 1 | 33 | 0 | 10⁻² | 0 | 386 | 0 |
10⁻³ | 0 | 1 | 0 | 10⁻³ | 0 | 58 | 0 |
500µL | Cell sheet | Cell sheet | 7 | 500µL | 0 | Cell sheet | 0 |